The Medical Advisor

Why Metabolism Is the Missing Link in Modern Medicine Cancer prevention, longevity, and metabolic health are usually discussed as separate domains. Oncology focuses on mutations. Aging research focuses on senescence and epigenetics. Metabolic health is reduced to weight, glucose, or cholesterol. This siloed thinking misses a deeper unifying driver. The common thread connecting cancer risk, cancer outcomes, and biological aging is metabolic signaling —specifically insulin resistance and mitochondrial dysfunction. This article lays out a single, coherent framework: Insulin resistance drives mitochondrial dysfunction, which erodes metabolic flexibility. That environment accelerates aging and creates fertile ground for cancer. 1. Insulin Resistance Is Not a Blood Sugar Problem Insulin resistance (IR) is often framed as a pre-diabetic condition. In reality, it is a whole-cell signaling disorder . When insulin signaling is impaired: Cells fail to take up glucose efficiently Circulating insul...

TL;DR  Best weight loss:  Mounjaro Best overall balance:  Wegovy Safest long-term data:  Semaglutide class Most overlooked truth:  benefits extend beyond weight Introduction: The GLP-1 Era Has Changed Medicine Over the past decade, a new class of medications— GLP-1 receptor agonists and incretin-based therapies —has fundamentally reshaped how we treat: Obesity Type 2 diabetes Cardiovascular risk Drugs like Ozempic, Wegovy, Mounjaro, and Trulicity are no longer niche therapies. They are now: Among the most prescribed metabolic drugs globally Central to what some call the “Ozempic economy” Positioned as potential lifespan-extending interventions But with rapid adoption comes confusion—and increasingly polarized narratives: One side: “These drugs are miracle breakthroughs” The other: “We don’t fully understand them—are they risky?” The truth sits in between. This guide cuts through both hype and fear to answer one question: Which GLP-1 drug is best—and what are th...

Introduction A 2023 study  described insulin resistance as a “silent driver” of pancreatic cancer. While directionally correct, this claim requires careful interpretation in light of newer (2023–2026) evidence. Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers globally. Increasing attention has shifted toward metabolic dysfunction—especially insulin resistance—as a modifiable risk factor. How insulin resistance may contribute to the development of cancer. Illustration by The Epoch Times, Shutterstock But how strong is the evidence? 🔬 2025–2026 Evidence Update: Strong Association, Uncertain Causation 1. Epidemiology: Consistent but Not Definitive Recent large-scale analyses confirm: Type 2 diabetes → ~1.5–2.0× increased pancreatic cancer risk Elevated fasting glucose → dose-dependent risk increase Obesity + metabolic syndrome → independent contributors 👉 A 2024–2025 pooled analysis (multi-cohort metabolic studies) reinforced: Hyperinsulinemia precedes ...

Introduction Modern diets—rich in sugar and ultra-processed foods—are strongly linked to rising rates of Type 2 Diabetes, Metabolic Syndrome, and Insulin Resistance. Low-carbohydrate and Ketogenic Diet diets have gained popularity as tools to reverse these conditions, but the full picture is nuanced and requires careful evidence-based interpretation. This guide connects the root causes, mechanisms, potential benefits, limitations, and a clinical framework for personalization. Part 1: The Root Cause — Sugar, Processed Foods, and Metabolic Dysfunction The Problem with Modern Diets Ultra-processed foods are: Rapidly digested Low in fiber Highly palatable and easy to overconsume These foods trigger frequent blood sugar spikes due to their high Glycemic Index. High intake of refined carbohydrates is associated with hyperinsulinemia and increased risk of obesity and type 2 diabetes. (1, 2) Insulin: The Central Driver When blood sugar rises, the pancreas releases Insulin, which: Lowers blood ...

Executive Summary: Ultra-Processed Foods and Your Health This article explains the health concerns associated with ultra-processed foods (UPFs) —industrial products that typically contain many ingredients, additives, preservatives, artificial flavors, and colors and are designed for convenience, long shelf life, and palatability. It outlines evidence linking high consumption of these foods with widespread negative health outcomes and urges greater awareness of what we eat. Definition and Classification UPFs fall under the highest category (Group 4) in the NOVA food classification system, distinguishing them from unprocessed and minimally processed foods like fruits, vegetables, whole grains, and fresh meat. Major Health Risks Research shows that diets high in ultra-processed foods are associated with poorer health outcomes across multiple bodily systems . A broad umbrella review found consistent links between UPF intake and 32 different adverse health effects, including meta...

The statement “sugar feeds cancer” is widespread — but incomplete. The relationship between sugar and cancer is not as simple as eliminating sugar to stop tumor growth. However, metabolic dysfunction, chronic hyperinsulinemia, and high glycemic load diets are increasingly recognized as contributors to cancer risk and possibly progression. This article clarifies what we know — and what we don’t. Sugars ‘Nourish’ Cancer Cells For cancer patients, “sugar intake can indeed nourish cancer cells,” Mingyang Song, associate professor of clinical epidemiology and nutrition at the Harvard T.H. Chan School of Public Health, told The Epoch Times. This is supported by strong epidemiological evidence, he said. Soft drinks on shelves in Riga, Latvia. Sugary drinks are prevalent across the world. (Tanya Keisha/Shutterstock) A study published in PLoS One involving 1,011 colon cancer patients with a follow-up period of over seven years found that compared to patients consuming less than two servings ...